Management of Relapsed/Refractory Mantle Cell Lymphoma

This chapter discusses the approach to managing relapsed/refractory mantle cell lymphoma in both younger and older patients. It covers topics such as the use of transplant, treatment options, including BTK inhibitors and CAR T-cell therapy, and ongoing clinical trials. The chapter also addresses the role of maintenance therapy and highlights the need for randomized data to guide treatment decisions.